Article Type
Changed
Mon, 05/15/2023 - 17:24

Key clinical point: Data from a multi-institutional US database of more than 2.5 million screening mammograms showed that digital breast tomosynthesis (DBT) was superior to digital mammography (DM) for the purpose of breast cancer (BC) screening.

 

Major finding: Compared with DM, DBT led to significantly higher cancer detection rates (adjusted odds ratio [OR] 1.24), biopsy rate (adjusted OR 1.33), and positive predictive value of recall (adjusted OR 1.33; all P < .001).

 

Study details: Findings are from a retrospective study including 2,528,063 screening mammograms in 1,100,447 women aged 40-79 years.

 

Disclosures: This study did not report the source of funding. Some authors declared receiving grants, travel support, consulting fees, or payments from various sources.

 

Source: Conant EF et al. Mammographic screening in routine practice: Multisite study of digital breast tomosynthesis and digital mammography screenings. Radiology. 2023 (Mar 14). Doi: 10.1148/radiol.221571

 

Publications
Topics
Sections

Key clinical point: Data from a multi-institutional US database of more than 2.5 million screening mammograms showed that digital breast tomosynthesis (DBT) was superior to digital mammography (DM) for the purpose of breast cancer (BC) screening.

 

Major finding: Compared with DM, DBT led to significantly higher cancer detection rates (adjusted odds ratio [OR] 1.24), biopsy rate (adjusted OR 1.33), and positive predictive value of recall (adjusted OR 1.33; all P < .001).

 

Study details: Findings are from a retrospective study including 2,528,063 screening mammograms in 1,100,447 women aged 40-79 years.

 

Disclosures: This study did not report the source of funding. Some authors declared receiving grants, travel support, consulting fees, or payments from various sources.

 

Source: Conant EF et al. Mammographic screening in routine practice: Multisite study of digital breast tomosynthesis and digital mammography screenings. Radiology. 2023 (Mar 14). Doi: 10.1148/radiol.221571

 

Key clinical point: Data from a multi-institutional US database of more than 2.5 million screening mammograms showed that digital breast tomosynthesis (DBT) was superior to digital mammography (DM) for the purpose of breast cancer (BC) screening.

 

Major finding: Compared with DM, DBT led to significantly higher cancer detection rates (adjusted odds ratio [OR] 1.24), biopsy rate (adjusted OR 1.33), and positive predictive value of recall (adjusted OR 1.33; all P < .001).

 

Study details: Findings are from a retrospective study including 2,528,063 screening mammograms in 1,100,447 women aged 40-79 years.

 

Disclosures: This study did not report the source of funding. Some authors declared receiving grants, travel support, consulting fees, or payments from various sources.

 

Source: Conant EF et al. Mammographic screening in routine practice: Multisite study of digital breast tomosynthesis and digital mammography screenings. Radiology. 2023 (Mar 14). Doi: 10.1148/radiol.221571

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Breast Cancer May 2023
Gate On Date
Tue, 06/22/2021 - 11:15
Un-Gate On Date
Tue, 06/22/2021 - 11:15
Use ProPublica
CFC Schedule Remove Status
Tue, 06/22/2021 - 11:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article